Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Oct 2, 2010
By:
Christopher B. Fox, Timothy S. Dutill, James Chesko, Ryan C. Anderson, Steven G. Reed, Thomas S. Vedvick
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
|